PFBT
TNGX icon

Parkside Financial Bank & Trust’s Tango Therapeutics TNGX Stock Holding History

Parkside Financial Bank & Trust’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.09K Hold
35
– – ﹤0.01% 2371
2026
Q1 		$733 Buy
+35
New +$487 ﹤0.01% 2452

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Parkside Financial Bank & Trust's TNGX Position: Q2 2026 in Review

Parkside Financial Bank & Trust held its Tango Therapeutics (TNGX) position steady in Q2 2026 at 35 shares worth $1.09K. The position accounts for ﹤0.01% of the portfolio, ranked #2371.

Parkside Financial Bank & Trust first reported a position in TNGX in Q1 2026 and has held it in 2 quarters since. 248 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Parkside Financial Bank & Trust held 35 shares of Tango Therapeutics worth $1.09K as of Q2 2026.
  • Parkside Financial Bank & Trust left its Tango Therapeutics share count unchanged in Q2 2026.
  • Tango Therapeutics made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #2371 holding.
  • Parkside Financial Bank & Trust first reported a position in Tango Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 248 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.